カテゴリー： Grand View Research, 世界, 医療/バイオ

C反応性蛋白（CRP）検査のグローバル市場2023-2030：ELISA、CLIA

◆英語タイトル：C-reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type (ELISA, CLIA), By Detection Range, By Disease Area, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが発行した調査報告書（GRV23SEP061）◆商品コード：GRV23SEP061
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2023年8月
◆ページ数：129
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：臨床診断
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

C反応性蛋白（CRP）検査市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界のC反応性蛋白（CRP）検査市場規模は2030年までに56億7000万米ドルに達する見込みで、2023年から2030年までのCAGRは0.26%で成長すると予測されています。C反応性蛋白（CRP）検査の成長は、検査の様々な用途の探求を目的とした重要な研究活動に起因しています。こうした研究努力は、この分野の研究を促進するための資金を提供する民間および公的機関の存在によってさらに促進されています。ナノテクノロジー・ツールの進歩により、市場は大きな成長が見込まれます。これらの進歩は、高い特異性、感度、迅速な応答時間、ポイント・オブ・ケアでの正確な疾患診断とモニタリングのための多重化能力などの特性を持つポータブル生物分析アッセイを開発する有望な機会を提供します。

これらの進歩は、予測期間中にC反応性蛋白（CRP）検査の需要を促進すると予想されます。さらに、戦略的取引や開発の増加、研究開発への投資の増加が成長を促進しています。C反応性蛋白（CRP）は感染症や炎症の重症度を評価するための重要なバイオマーカーと考えられているため、COVID-19の流行は市場に大きな影響を与えています。その結果、サービスや製品に対する需要が高まっています。アボット社などの大手企業は、SARS-CoV-2感染に特化したC反応性蛋白（CRP）検査用の支援ツールを提供しており、市場の成長にさらに貢献しています。さらに、主要企業は製品の発売やポイントオブケアC反応性蛋白（CRP）検査の開発に注力するようになり、これが今後数年間の市場の成長をさらに促進すると予測されています。

例えば、2022年7月、Bloom Diagnostics社は、血液中のCRP値を定量化するために設計された半自動検査キットであるBloom Inflammation Testを発表しました。このシングルユースのキットは、体内の炎症の検出に役立ちます。市場の成長は、検査施設の設立によってさらに刺激されると予想されます。2021年6月、トリビトロン・ヘルスケアはCOVID-19診断用の移動ラボを発表し、農村部、都市部、遠隔地を含むインドのさまざまな地域での検査サービスを可能にしました。この研究所は、CRP、IL-6、D-ダイマーなどの炎症マーカーのCLIA/Elisa検査、迅速抗原検査、RT-PCR検査、CLIA/Elisa抗体検査IgMおよびIgGなど、さまざまな検査を提供しています。

北米は2022年に39.42%の最大収益シェアを占め、心血管疾患の有病率の増加、着実な製品上市、確立された市場プレイヤーの存在、技術の進歩、整備された医療インフラにより、予測期間中もそのシェアを維持する見込みです。アジア太平洋地域は、2023年から2030年にかけて最も速いCAGR 0.49％で成長すると予測されています。COVID-19パンデミックは中国発。感染症の重症度を判定するバイオマーカーとなる可能性があるため、C反応性蛋白（CRP）検査の需要は間もなく増加する見込みです。世界的な業界で事業を展開する主要企業は、その存在感を維持するために、製品の発売と地理的拡大に絶えず注力しています。

C反応性蛋白（CRP）検査市場レポートハイライト

- アッセイタイプ別では、免疫比濁法アッセイセグメントが2022年に48.53%の最大収益シェアを占めました。サンプル中のCRPレベルを正確に検出するための広い測定範囲を提供する、高感度で自動化された費用対効果の高い免疫比濁アッセイの導入に起因します。

- 検出範囲に基づくと、2022年にはhs-CRPセグメントが約42.80%の売上シェアで市場を支配しました。hs-CRPは、従来のCRPに比べて検出範囲が広いことが特徴です。

- 疾患領域別では、心血管疾患分野が2022年に最大の市場シェアを占め、予測期間を通じて市場を支配すると予測されます。CVDの有病率の増加がC反応性蛋白（CRP）検査市場の成長に寄与する主な要因です。

- 特にCOVID-19の大流行を受けて病院でのC反応性蛋白（CRP）検査導入が増加したため、2022年の市場シェアは病院エンドユーザー部門が28.01%で独占しました。これにより検査率が上昇し、同セグメントの成長に貢献しました。

- さらに、慢性心疾患や癌の有病率の増加により、市場は成長を遂げています。これらの疾患の診断、管理、モニタリングにおけるC反応性蛋白（CRP）検査の需要が高まっているためです。

第1章．調査手法＆範囲
第2章．エグゼクティブサマリー
第3章．市場変動・動向・範囲
第4章．アッセイタイプ別分析
第5章．検出範囲別分析
第6章．疾患領域別分析
第7章．最終用途別分析
第8章．地域別分析
第9章．競合状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objective
1.9.1. Objective – 1
1.9.2. Objective – 2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing R&D in the field of C-reactive protein testing
3.2.1.2. Rising incidence of chronic disorders
3.2.2. Market Restraint Analysis
3.2.2.1. Availability of alternative disease testing methods
3.2.3. Market Opportunity Analysis
3.2.3.1. Technological advancements pertaining to conventional CRP tests
3.2.3.2. Growing adoption of point-of-care tests
3.2.4. Market Threat Analysis
3.2.4.1. Threat analysis on conventional CRP tests
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Assay Type Business Analysis
4.1. C-reactive Protein (CRP) Testing Market: Assay Type Movement Analysis
4.2. Immunoturbidimetric Assay
4.2.1. Immunoturbidimetric Assay Market, 2018 – 2030 (USD Million)
4.3. ELISA
4.3.1. ELISA Market, 2018 – 2030 (USD Million)
4.3.2. Clinical ELISA
4.3.2.1. Clinical ELISA Market, 2018 – 2030 (USD Million)
4.3.3. Nonclinical ELISA
4.3.3.1. Nonclinical ELISA Market, 2018 – 2030 (USD Million)
4.4. Chemiluminescence Immunoassay
4.4.1. Chemiluminescence Immunoassay Market, 2018 – 2030 (USD Million)
4.5. Others
4.5.1. Others Market, 2018 – 2030 (USD Million)
Chapter 5. Detection Range Business Analysis
5.1. C-reactive Protein (CRP) Testing Market: Detection Range Movement Analysis
5.2. High Sensitivity C-reactive Protein (hs-CRP)
5.2.1. High Sensitivity C-reactive Protein (hs-CRP) Market, 2018 – 2030 (USD Million)
5.3. Conventional CRP
5.3.1. Conventional CRP Market, 2018 – 2030 (USD Million)
5.4. Cardiac CRP (cCRP)
5.4.1. Cardiac CRP (CCRP) Market, 2018 – 2030 (USD Million)
Chapter 6. Disease Area Business Analysis
6.1. C-reactive Protein (CRP) Testing Market: Disease Area Movement Analysis
6.2. Cardiovascular Diseases
6.2.1. Cardiovascular Diseases Market, 2018 – 2030 (USD Million)
6.3. Cancer
6.3.1. Cancer Market, 2018 – 2030 (USD Million)
6.4. Rheumatoid Arthritis
6.4.1. Rheumatoid Arthritis Market, 2018 – 2030 (USD Million)
6.5. Inflammatory Bowel Disease
6.5.1. Inflammatory Bowel Disease Market, 2018 – 2030 (USD Million)
6.6. Endometriosis
6.6.1. Endometriosis Market, 2018 – 2030 (USD Million)
6.7. Lupus
6.7.1. Lupus Market, 2018 – 2030 (USD Million)
6.8. Others
6.8.1. Others Market, 2018 – 2030 (USD Million)
Chapter 7. End-use Business Analysis
7.1. C-reactive Protein (CRP) Testing Market: End-use Movement Analysis
7.2. Clinics
7.2.1. Clinics Market, 2018 – 2030 (USD Million)
7.2.2. Clinics, by entity
7.2.2.1. Physician offices
7.2.2.1.1. Physician Offices Market, 2018 – 2030 (USD Million)
7.2.2.2. Small clinics
7.2.2.2.1. Small Clinics Market, 2018 – 2030 (USD Million)
7.2.2.3. Others
7.2.2.3.1. Others Market, 2018 – 2030 (USD Million)
7.2.3. Clinics, by setting
7.2.3.1. Urban setting
7.2.3.1.1. Urban Setting Market, 2018 – 2030 (USD Million)
7.2.3.2. Rural settings
7.2.3.2.1. Rural Settings Market, 2018 – 2030 (USD Million)
7.3. Hospitals
7.3.1. Hospitals Market, 2018 – 2030 (USD Million)
7.3.2. Urban setting
7.3.2.1. Urban Setting Market, 2018 – 2030 (USD Million)
7.3.3. Rural settings
7.3.3.1. Rural Settings Market, 2018 – 2030 (USD Million)
7.4. Laboratories
7.4.1. Laboratories Market, 2018 – 2030 (USD Million)
7.4.2. Urban setting
7.4.2.1. Urban Setting Market, 2018 – 2030 (USD Million)
7.4.3. Rural settings
7.4.3.1. Rural Settings Market, 2018 – 2030 (USD Million)
7.5. Assisted Living Healthcare Facilities
7.5.1. Assisted Living Healthcare Facilities Market, 2018 – 2030 (USD Million)
7.5.2. Urban setting
7.5.2.1. Urban Setting Market, 2018 – 2030 (USD Million)
7.5.3. Rural settings
7.5.3.1. Rural Settings Market, 2018 – 2030 (USD Million)
7.6. Home
7.6.1. Home Market, 2018 – 2030 (USD Million)
7.7. Others
7.7.1. Others Market, 2018 – 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. C-reactive Protein (CRP) Testing Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.2.3. U.S.
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. U.S. C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.2.4. Canada
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Canada C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.3. North America
8.3.1. SWOT Analysis
8.3.2. North America C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.3.3. U.S.
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. U.S. C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.3.4. Canada
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Canada C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.4. Europe
8.4.1. SWOT Analysis
8.4.2. Europe C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.4.3. UK
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. UK C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.4.4. Germany
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Germany C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.4.5. France
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. France C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.4.6. Italy
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Italy C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.4.7. Spain
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Spain C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.4.8. Sweden
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Sweden C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.4.9. Norway
8.4.9.1. Key Country Dynamics
8.4.9.2. Competitive Scenario
8.4.9.3. Regulatory Framework
8.4.9.4. Norway C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.4.10. Denmark
8.4.10.1. Key Country Dynamics
8.4.10.2. Competitive Scenario
8.4.10.3. Regulatory Framework
8.4.10.4. Denmark C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.5. Asia Pacific
8.5.1. SWOT Analysis
8.5.2. Asia Pacific C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.5.3. China
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. China C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.5.4. India
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. India C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.5.5. Japan
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Japan C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.5.6. Thailand
8.5.6.1. Key Country Dynamics
8.5.6.2. Competitive Scenario
8.5.6.3. Regulatory Framework
8.5.6.4. Thailand C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.5.7. South Korea
8.5.7.1. Key Country Dynamics
8.5.7.2. Competitive Scenario
8.5.7.3. Regulatory Framework
8.5.7.4. South Korea C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.5.8. Australia
8.5.8.1. Key Country Dynamics
8.5.8.2. Competitive Scenario
8.5.8.3. Regulatory Framework
8.5.8.4. Australia C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.6. Latin America
8.6.1. SWOT Analysis
8.6.2. Latin America C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.6.3. Brazil
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Brazil C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.6.4. Mexico
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Mexico C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.6.5. Argentina
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Argentina C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.7. MEA
8.7.1. SWOT Analysis
8.7.2. MEA C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. Saudi Arabia C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.7.4. South Africa
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. South Africa C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.7.5. UAE
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. UAE C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
8.7.6. Kuwait
8.7.6.1. Key Country Dynamics
8.7.6.2. Competitive Scenario
8.7.6.3. Regulatory Framework
8.7.6.4. Kuwait C-reactive Protein (CRP) Testing Market, 2018 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. F. Hoffmann-La Roche Ltd
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Danaher
9.4.2.1. Overview
9.4.2.1.1. Beckman Coulter, Inc.
9.4.2.1.2. Radiometer
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Thermo Fisher Scientific Inc.
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Quest Diagnostics Incorporated
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Siemens
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Abbott Laboratories
9.4.6.1. Overview
9.4.6.1.1. Alere Inc.
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Laboratory Corporation of America Holdings (LabCorp)
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Merck KGaA
9.4.8.1. Overview
9.4.8.1.1. Sigma-Aldrich Co. LLC.
9.4.8.1.2. Merck Millipore
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Abaxis, Inc.
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Ortho Clinical Diagnostics
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. Getein Biotech, Inc.
9.4.11.1. Overview
9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.11.3. Product Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. HORIBA, Ltd.
9.4.12.1. Overview
9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.12.3. Product Benchmarking
9.4.12.4. Strategic Initiatives
9.4.13. RandoxLaboratories Ltd.
9.4.13.1. Overview
9.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.13.3. Product Benchmarking
9.4.13.4. Strategic Initiatives
9.4.14. BODITECH MED, INC
9.4.14.1. Overview
9.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.14.3. Product Benchmarking
9.4.14.4. Strategic Initiatives
9.4.15. Aidian
9.4.15.1. Overview
9.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.15.3. Product Benchmarking
9.4.15.4. Strategic Initiatives
9.4.16. EurolyserDiagnostica GmbH
9.4.16.1. Overview
9.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.16.3. Product Benchmarking
9.4.16.4. Strategic Initiatives
9.4.17. Abcam plc
9.4.17.1. Overview
9.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.17.3. Product Benchmarking
9.4.17.4. Strategic Initiatives
9.4.18. Bio-Techne
9.4.18.1. Overview
9.4.18.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.18.3. Product Benchmarking
9.4.18.4. Strategic Initiatives
9.4.19. EKF Diagnostics
9.4.19.1. Overview
9.4.19.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.19.3. Product Benchmarking
9.4.19.4. Strategic Initiatives
9.4.20. SD Biosensor, INC.
9.4.20.1. Overview
9.4.20.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.20.3. Product Benchmarking
9.4.20.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 4 Global C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 5 Global C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 6 Global C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 7 Global C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 8 Global C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 9 Global C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 10 Global C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 11 Global C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 12 Global C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 13 North America C-Reactive Protein (CRP) Testing Market, By Country, 2018 - 2030 (USD Million)
Table 14 North America C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 15 North America C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 16 North America C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 17 North America C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 18 North America C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 19 North America C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 20 North America C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 21 North America C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 22 North America C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 23 North America C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 24 U.S. C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 25 U.S. C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 26 U.S. C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 27 U.S. C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 28 U.S. C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 29 U.S. C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 30 U.S. C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 31 U.S. C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 32 U.S. C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 33 U.S. C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 34 Canada C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 35 Canada C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 36 Canada C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 37 Canada C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 38 Canada C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 39 Canada C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 40 Canada C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 41 Canada C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 42 Canada C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 43 Canada C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 44 Europe C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 45 Europe C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 46 Europe C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 47 Europe C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 48 Europe C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 49 Europe C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 50 Europe C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 51 Europe C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 52 Europe C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 53 Europe C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 54 Germany C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 55 Germany C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 56 Germany C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 57 Germany C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 58 Germany C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 59 Germany C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 60 Germany C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 61 Germany C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 62 Germany C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 63 Germany C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 64 UK C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 65 UK C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 66 UK C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 67 UK C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 68 UK C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 69 UK C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 70 UK C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 71 UK C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 72 UK C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 73 UK C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 74 France C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 75 France C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 76 France C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 77 France C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 78 France C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 79 France C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 80 France C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 81 France C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 82 France C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 83 France C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 84 Italy C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 85 Italy C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 86 Italy C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 87 Italy C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 88 Italy C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 89 Italy C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 90 Italy C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 91 Italy C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 92 Italy C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 93 Italy C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 94 Spain C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 95 Spain C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 96 Spain C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 97 Spain C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 98 Spain C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 99 Spain C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 100 Spain C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 101 Spain C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 102 Spain C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 103 Spain C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 104 Sweden C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 105 Sweden C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 106 Sweden C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 107 Sweden C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 108 Sweden C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 109 Sweden C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 110 Sweden C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 111 Sweden C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 112 Sweden C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 113 Sweden C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 114 Denmark C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 115 Denmark C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 116 Denmark C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 117 Denmark C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 118 Denmark C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 119 Denmark C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 120 Denmark C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 121 Denmark C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 122 Denmark C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 123 Denmark C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 124 Norway C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 125 Norway C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 126 Norway C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 127 Norway C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 128 Norway C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 129 Norway C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 130 Norway C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 131 Norway C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 132 Norway C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 133 Norway C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 134 Asia Pacific C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 135 Asia Pacific C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 136 Asia Pacific C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 137 Asia Pacific C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 138 Asia Pacific C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 139 Asia Pacific C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 140 Asia Pacific C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 141 Asia Pacific C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 142 Asia Pacific C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 143 Asia Pacific C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 144 Japan C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 145 Japan C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 146 Japan C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 147 Japan C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 148 Japan C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 149 Japan C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 150 Japan C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 151 Japan C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 152 Japan C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 153 Japan C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 154 China C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 155 China C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 156 China C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 157 China C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 158 China C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 159 China C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 160 China C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 161 China C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 162 China C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 163 China C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 164 India C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 165 India C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 166 India C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 167 India C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 168 India C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 169 India C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 170 India C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 171 India C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 172 India C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 173 India C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 174 Australia C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 175 Australia C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 176 Australia C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 177 Australia C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 178 Australia C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 179 Australia C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 180 Australia C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 181 Australia C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 182 Australia C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 183 Australia C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 184 South Korea C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 185 South Korea C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 186 South Korea C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 187 South Korea C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 188 South Korea C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 189 South Korea C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 190 South Korea C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 191 South Korea C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 192 South Korea C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 193 South Korea C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 194 Thailand C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 195 Thailand C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 196 Thailand C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 197 Thailand C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 198 Thailand C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 199 Thailand C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 200 Thailand C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 201 Thailand C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 202 Thailand C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 203 Thailand C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 204 Latin America C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 205 U.S. C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 206 Latin America C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 207 Latin America C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 208 U.S. C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 209 Latin America C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 210 Latin America C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 211 Latin America C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 212 Latin America C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 213 Latin America C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 214 Brazil C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 215 Brazil C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 216 Brazil C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 217 Brazil C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 218 Brazil C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 219 Brazil C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 220 Brazil C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 221 Brazil C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 222 Brazil C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 223 Brazil C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 224 Mexico C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 225 Mexico C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 226 Mexico C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 227 Mexico C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 228 Mexico C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 229 Mexico C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 230 Mexico C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 231 Mexico C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 232 Mexico C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 233 Mexico C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 234 Argentina C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 235 Argentina C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 236 Argentina C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 237 Argentina C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 238 Argentina C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 239 Argentina C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 240 Argentina C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 241 Argentina C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 242 Argentina C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 243 Argentina C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 244 MEA C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 245 MEA C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 246 MEA C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 247 MEA C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 248 MEA C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 249 MEA C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 250 MEA C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 251 MEA C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 252 MEA C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 253 MEA C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 254 South Africa C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 255 South Africa C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 256 South Africa C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 257 South Africa C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 258 South Africa C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 259 South Africa C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 260 South Africa C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 261 South Africa C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 262 South Africa C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 263 South Africa C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 264 Saudi Arabia C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 265 Saudi Arabia C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 266 Saudi Arabia C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 267 Saudi Arabia C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 268 Saudi Arabia C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 269 Saudi Arabia C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 270 Saudi Arabia C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 271 Saudi Arabia C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 272 Saudi Arabia C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 273 Saudi Arabia C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 274 UAE C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 275 UAE C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 276 UAE C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 277 UAE C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 278 UAE C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 279 UAE C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 280 UAE C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 281 UAE C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 282 UAE C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 283 UAE C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 284 Kuwait C-reactive protein testing market, by assay type, 2018 - 2030 (USD Million)
Table 285 Kuwait C-reactive protein testing market for ELISA, by type, 2018 - 2030 (USD Million)
Table 286 Kuwait C-reactive protein testing market, by detection range, 2018 - 2030 (USD Million)
Table 287 Kuwait C-reactive protein testing market, by disease area, 2018 - 2030 (USD Million)
Table 288 Kuwait C-reactive protein testing market, by end-use, 2018 - 2030 (USD Million)
Table 289 Kuwait C-reactive protein testing market for clinics, by entity type, 2018 - 2030 (USD Million)
Table 290 Kuwait C-reactive protein testing market for clinics, by setting type, 2018 - 2030 (USD Million)
Table 291 Kuwait C-reactive protein testing market for hospital, by setting type, 2018 - 2030 (USD Million)
Table 292 Kuwait C-reactive protein testing market for laboratories, by setting type, 2018 - 2030 (USD Million)
Table 293 Kuwait C-reactive protein testing market for assisted living healthcare facilities, by setting type, 2018 - 2030 (USD Million)
Table 294 List of key emerging companies

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ C反応性蛋白（CRP）検査のグローバル市場2023-2030：ELISA、CLIA(C-reactive Protein Testing Market Size, Share & Trends Analysis Report By Assay Type (ELISA, CLIA), By Detection Range, By Disease Area, By End-use, By Region, And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • C反応性タンパク質検査のグローバル市場2023-2030：ELISA、CLIA
  • 世界の血液スクリーニング市場2023-2030：技術別（NAT、ELISA、CLIA & EIA、NGS、ウェスタンブロッティング）、製品別（試薬、機器）、地域別
  • 血液検査のグローバル市場2023-2030：ブドウ糖、脂質、新型コロナウイルス感染症、A1C、CRP、ビタミンD、ALT、AST、甲状腺刺激ホルモン、PSA、コルチゾール
  • 血液検査のグローバル市場2023-2030：ブドウ糖、脂質、新型コロナウイルス感染症、A1C、CRP、ビタミンD、ALT、AST、甲状腺刺激ホルモン、PSA、コルチゾール
  • 産業用微生物試験サービスのグローバル市場2023-2030：無菌性試験、微生物限度試験

    • ◆H&Iグローバルリサーチのお客様（例）◆